Latest Breaking News On - Phase 1b prime hcc trial - Page 1 : comparemela.com

Neoadjuvant treatment with the combination of nivolumab and ipilimumab led to responses and was well tolerated in patients with resectable hepatocellular carcinoma.

United kingdomComunidad autonoma de catalunaAntonio dalessioInternational liver cancer association conferenceImperial college of london at hammersmith hospitalLiver cancer associationImperial collegeHammersmith hospitalBarcelona clinic liver cancerGastrointestinal cancerEsectable hepatocellular carcinomaPhase 1b prime hcc trial2023 international liver cancer association conference